The latest closing stock price for Entrada Therapeutics as of November 20, 2024 is 17.93.
An investor who bought $1,000 worth of Entrada Therapeutics stock at the IPO in 2021 would have $-251 today, roughly 0 times their original investment - a -9.20% compound annual growth rate over 3 years.
The all-time high Entrada Therapeutics stock closing price was 35.00 on November 17, 2021.
The Entrada Therapeutics 52-week high stock price is 20.49, which is 14.3% above the current share price.
The Entrada Therapeutics 52-week low stock price is 10.95, which is 38.9% below the current share price.
The average Entrada Therapeutics stock price for the last 52 weeks is 15.08.
An investor who bought $1,000 worth of Entrada Therapeutics stock at the IPO in 2021 would have $-251 today, roughly 0 times their original investment - a -9.20% compound annual growth rate over 3 years.
The all-time high Entrada Therapeutics stock closing price was 35.00 on November 17, 2021.
The Entrada Therapeutics 52-week high stock price is 20.49, which is 14.3% above the current share price.
The Entrada Therapeutics 52-week low stock price is 10.95, which is 38.9% below the current share price.
The average Entrada Therapeutics stock price for the last 52 weeks is 15.08.